In summary, CircZFR functions as a central oncogenic driver in PC, facilitating tumor progression through the regulation of key signaling pathways, including BCLAF1, Rho/RTKN2, and the miR-375/GREM2/JNK axis. This evidence concerns the gene RTKN2 and pachyonychia congenita.